Glioblastoma Multiforme
4 competing products in clinical development for Glioblastoma Multiforme.
Pipeline by Phase
Pre-clinical1
Phase 1/22
Phase 21
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Gliadel + Avastin + Temodar | Eisai | Phase 2 | Terminated | 27 |
| Temferon | Genenta Science | Phase 1/2 | Active | 26 |
| KHK2455 | Kyowa Kirin | Pre-clinical | Completed | 26 |
| BCNU Wafer + Irinotecan + Bevacizumab | Eisai | Phase 1/2 | Withdrawn | 24 |